Latest Industry Insights

Industry Insight
Expanding the Drug Target Universe: How Next-Generation Proteomics Is Transforming Oncology Research
Cutting-edge mass spectrometry proteomics technologies are accelerating the discovery and validation of novel targets in cancer, opening up new avenues for next-generation cancer therapeutics.

Industry Insight
Next-Generation Proteomics Solutions Set To Accelerate Targeted Therapies
Hear how the capabilities of mass spectrometry (MS)-based proteomics are proving themselves in drug development and discovery and what this means for those working in oncology.

Industry Insight
Quality Control for RNA Therapeutics: Meeting a Growing Need
New applications for RNA therapeutics are continuously emerging. In this burgeoning space, nucleic acid quantification can help this dynamic therapeutic modality reach its full potential.

Industry Insight
Ensuring Performance, Intelligence and Sustainability in MS
At ASMS, Technology Networks spoke with Ken Suzuki and Jennifer Gushue to learn more about how Agilent is addressing customer needs with novel “intelligence” features and the company’s efforts to ensure the sustainability and longevity of its products.

Industry Insight
The Challenges Facing Battery Manufacturers
Researchers have made significant strides toward developing improved battery chemistries, but scaling up production is challenging. To find out more, we spoke to Zhao Liu, senior market development manager at Thermo Fisher Scientific.

Industry Insight
Accelerating and Refining With Mass Spectrometry
At ASMS 2023, Technology Networks spoke with Dr. Chris Lock, vice president of global research and development at SCIEX, to discuss the newly launched Intabio ZT system.

Industry Insight
Increasing Throughput While Protecting Proteome Coverage
At ASMS 2023, Technology Networks spoke with Jim Yano, senior director of product management at Thermo Fisher Scientific, to learn more about the company's novel instrument launches and how they could be applied to personalized medicine.

Industry Insight
Advances in Mass Spectrometry Drive Immunopeptidomics
At the 71st Annual Society for Mass Spectrometry (ASMS) meeting, Technology Networks had the pleasure of speaking with Rohan Thakur, president of Life Sciences Mass Spectrometry at Bruker Daltonics. We discussed the new product launches from Bruker and focused specifically on the applications of the company’s newest mass spectrometer, the timsTOF Ultra, for immunopeptidomics.

Industry Insight
A Decade of DIA and Key Milestones: The 10-Year Anniversary of SWATH DIA
The 10-year anniversary of SWATH DIA signifies a period of immense growth that is only expected to continue to evolve, influencing a wide range of fields. This article explores key milestones for SWATH DIA since its development.

Industry Insight
Supporting Reproducibility and Accelerating Workflows With Automated Systems
At SLAS 2023, Technology Networks spoke with the PerkinElmer Life Sciences and Diagnostics organization to discuss the launch of two new automated platforms. These innovative systems are designed to improve workflows such as high-throughput drug discovery screening and next-generation sequencing library prep through advances in automation technologies.
Advertisement